Paysign, Inc. (PAYS) Stock Forecast
Data as of Aug 7, 2026Industrials · Current price $12.45 (+0.40%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
PAYS vs Sector & Market
| Metric | PAYS | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.41 | 2.42 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | -0.4% | +117.9% | +17.2% |
| P/E Ratio | 47.85 | 38.87 | 36.06 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $27M | $27M | $27M | 1 |
| 2026-12-31 | $27M | $27M | $27M | 2 |
| 2027-03-31 | $30M | $31M | $31M | 1 |
| 2027-06-30 | $30M | $30M | $30M | 2 |
| 2027-09-30 | $30M | $30M | $31M | 2 |
| 2027-12-31 | $30M | $31M | $31M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.05 | $0.06 | $0.06 | 1 |
| 2026-12-31 | $0.05 | $0.05 | $0.05 | 2 |
| 2027-03-31 | $0.08 | $0.08 | $0.08 | 2 |
| 2027-06-30 | $0.07 | $0.07 | $0.07 | 1 |
| 2027-09-30 | $0.07 | $0.07 | $0.07 | 1 |
| 2027-12-31 | $0.06 | $0.07 | $0.07 | 2 |
Frequently Asked Questions
What is the analyst consensus for PAYS?
The consensus among 3 analysts covering Paysign, Inc. (PAYS) is Buy with an average price target of $9.00.
What is the highest price target for PAYS?
The highest analyst price target for PAYS is $9.00.
What is the lowest price target for PAYS?
The lowest analyst price target for PAYS is $9.00.
How many analysts cover PAYS?
3 analysts have issued ratings for Paysign, Inc. in the past 12 months.
Is PAYS a buy or sell right now?
Based on 3 analyst ratings, PAYS has a consensus rating of Buy (2.00/5) with a -0.4% upside to the consensus target of $9.00.
What are the earnings estimates for PAYS?
Analysts estimate PAYS will report EPS of $0.06 for the period ending 2026-09-30, with revenue estimated at $27M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.